[--[65.84.65.76]--]
Indian-news  

Stock-news

 13 Aug 2026 01:07 PM

DHUNSERI INVESTMENTS: Q1 EBITDA 1.17B RUPEES VS 932M (YOY) || Q1 EBITDA MARGIN 45.4% VS 54.33% (YOY)

DHUNSERI INVESTMENTS: Q1 EBITDA 1.17B RUPEES VS 932M (YOY) || Q1 EBITDA MARGIN 45.4% VS 54.33% (YOY)

 13 Aug 2026 01:07 PM

DHUNSERI INVESTMENTS: Q1 REVENUE 2.6B RUPEES VS 1.7B (YOY)

DHUNSERI INVESTMENTS: Q1 REVENUE 2.6B RUPEES VS 1.7B (YOY)

 13 Aug 2026 01:06 PM

DHUNSERI INVESTMENTS: Q1 CONS NET PROFIT 1.33B RUPEES VS 530M (YOY)

DHUNSERI INVESTMENTS: Q1 CONS NET PROFIT 1.33B RUPEES VS 530M (YOY)

 13 Aug 2026 01:01 PM

BAJAJ HINDUSTHAN SUGAR: Q1 EBITDA LOSS 1.2B RUPEES VS LOSS 268M (YOY)

BAJAJ HINDUSTHAN SUGAR: Q1 EBITDA LOSS 1.2B RUPEES VS LOSS 268M (YOY)

 13 Aug 2026 01:01 PM

BAJAJ HINDUSTHAN SUGAR: Q1 REVENUE 11.25B RUPEES VS 12.5B (YOY)

BAJAJ HINDUSTHAN SUGAR: Q1 REVENUE 11.25B RUPEES VS 12.5B (YOY)

 13 Aug 2026 01:00 PM

BAJAJ HINDUSTHAN SUGAR: Q1 CONS NET LOSS 1.8B RUPEES VS LOSS 1.7B (YOY)

BAJAJ HINDUSTHAN SUGAR: Q1 CONS NET LOSS 1.8B RUPEES VS LOSS 1.7B (YOY)

 13 Aug 2026 01:00 PM

JTEKT INDIA: Q1 REVENUE 7.2B RUPEES VS 5.66B (YOY)

JTEKT INDIA: Q1 REVENUE 7.2B RUPEES VS 5.66B (YOY)

 13 Aug 2026 01:00 PM

JTEKT INDIA: Q1 EBITDA 382M RUPEES VS 309M (YOY) || Q1 EBITDA MARGIN 5.32% VS 5.45% (YOY)

JTEKT INDIA: Q1 EBITDA 382M RUPEES VS 309M (YOY) || Q1 EBITDA MARGIN 5.32% VS 5.45% (YOY)

 13 Aug 2026 01:00 PM

JTEKT INDIA: Q1 SL NET PROFIT 62M RUPEES VS 108M (YOY)

JTEKT INDIA: Q1 SL NET PROFIT 62M RUPEES VS 108M (YOY)

 13 Aug 2026 12:58 PM

CESC: Q1 EBITDA 10.75B RUPEES VS 10.92B (YOY) || Q1 EBITDA MARGIN 19.6% VS 21.1% (YOY)

CESC: Q1 EBITDA 10.75B RUPEES VS 10.92B (YOY) || Q1 EBITDA MARGIN 19.6% VS 21.1% (YOY)

 13 Aug 2026 12:58 PM

CESC: Q1 REVENUE 54.85B RUPEES VS 52.02B (YOY)

CESC: Q1 REVENUE 54.85B RUPEES VS 52.02B (YOY)

 13 Aug 2026 12:57 PM

CESC: Q1 CONS NET PROFIT 4B RUPEES VS 3.87B (YOY)

CESC: Q1 CONS NET PROFIT 4B RUPEES VS 3.87B (YOY)

 13 Aug 2026 12:56 PM

THEMIS MEDICARE: Q1 CONS NET LBT 569M RUPEES VS LOSS 139M (YOY) || CO HAS PROFIT ON SALE OF SHARE 929M

THEMIS MEDICARE: Q1 CONS NET LBT 569M RUPEES VS LOSS 139M (YOY) || CO HAS PROFIT ON SALE OF SHARE 929M

 23 Apr 2024 10:36 PM   MoneyControl

ICICI Prudential Life Insurance to focus on growing absolute VNB amid slump in FY24

In its Q4FY24 results, the company's VNB fell 19.45 percent to Rs 2,227 crore for FY24

 23 Apr 2024 06:51 PM   MoneyControl

Tata Elxsi Q4 net profit, revenue decline QoQ; firm declares dividend of Rs 70 per share

The net profit was down 4.6 percent quarter-on-quarter compared to the October to December period of FY24 and 2.32 percent against the March quarter of FY23

 23 Apr 2024 06:26 PM   MoneyControl

ICICI Pru Life Q4 net profit falls 26% to Rs 174 cr, insurer announces dividend

Net premium income rose to Rs 14,788 crore

 23 Apr 2024 05:56 PM   MoneyControl

Cyient DLM's profit after tax in FY24 surges 93%

For the full year, the company's revenue stood at Rs 1,192 crore, which was 43.2 percent higher compared to the same period of the past financial year